Time-to-completion of COVID-19 vaccination primary series varies by HIV viral load status among people who inject drugs in Baltimore, Maryland

Baker, Pieter; Cepeda, Javier A; Schluth, Catherine; Astemborski, Jacquie; Feder, Kenneth A.; Rudolph, Jacqueline; Sun, Jing; Kirk, Gregory D.; Mehta, Shruti H.; Genberg, Becky L.

doi:10.1016/j.pmedr.2023.102448

Cited by 4 publications

(1 citation statement)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Few studies have been conducted to understand determinants of COVID-19 vaccination uptake among PWH in the United States; these studies report that younger age, lower education level, Hispanic ethnicity, rural residency, no history of recent influenza vaccination, having a transmission risk of injection drug use, no engagement in HIV care, and unsuppressed viral load negatively influence uptake of COVID-19 vaccination in this population. 7,8,10 Our study adds to the limited existing research among PWH by describing COVID-19 vaccine uptake and associated factors as well as common places of vaccination and reasons for no vaccination in a sample of racial/ethnic minority PWH in Miami-Dade County, FL. Our study focuses on the 3 predominant racial/ethnic minority groups with HIV in South Florida, Hispanic, Haitian, African American (excluding Haitian) groups 11 and examines COV-ID-19 vaccine uptake among Haitian PWH as a separate group from African American PWH due to linguistic and other cultural differences.…”

Section: Introductionmentioning

confidence: 98%

Factors Associated With COVID-19 Vaccination Among Racial/Ethnic Minority Groups With HIV in South Florida

Ramírez-Ortiz,

Jean-Gilles,

Sheehan

et al. 2024

JAIDS Journal of Acquired Immune Deficiency Syndromes

View full text Add to dashboard Cite

Background: Racial/ethnic minority groups with HIV in the United States are particularly vulnerable to COVID-19 consequences and can significantly benefit from increased uptake of COVID-19 vaccines. This study identified factors associated with full COVID-19 vaccination among people with HIV. Setting: Ryan White HIV/AIDS Program (RWP) in Miami-Dade County, Florida. Methods: Data were collected from 299 RWP adult clients during January–March 2022 using a cross-sectional phone survey. Multivariable logistic regression was used to estimate adjusted odds ratios (aORs) with 95% confidence intervals (CIs). All analyses were weighted to be representative of the race/ethnicity and sex distribution of clients in the RWP. Results: Eighty-four percent of participants were fully vaccinated with a primary vaccine series; stratified by race/ethnicity, the percentages were 88.9% of Hispanic, 72.0% of Black/African American, and 67.5% of Haitian participants. Fully vaccinated participants were less likely to be Black/African American than Hispanic (aOR=0.18; 95% CI=0.05-0.67) and more likely to not endorse any misconceptions about COVID-19 vaccines (aOR=8.26; 95% CI=1.38-49.64), to report encouragement to get vaccinated from sources of information (aOR=20.82; 95% CI=5.84-74.14), and to perceive that more than 50% of their social network was vaccinated (aOR=3.35; 95% CI=1.04-10.71). Experiences of healthcare discrimination, structural barriers to access vaccines, and recommendations from HIV providers were not associated with full vaccination. Conclusions: These findings highlight the importance of delivering accurate and positive messages about vaccines and engaging social networks to promote COVID-19 vaccination among PWH. This information can be leveraged to promote uptake of subsequent boosters and other recommended vaccines.

show abstract

Section: Introductionmentioning

confidence: 98%

Factors Associated With COVID-19 Vaccination Among Racial/Ethnic Minority Groups With HIV in South Florida

Ramírez-Ortiz,

Jean-Gilles,

Sheehan

et al. 2024

JAIDS Journal of Acquired Immune Deficiency Syndromes

View full text Add to dashboard Cite

show abstract

Uptake of COVID-19 Vaccination and Related Factors Among People who Inject Drugs, San Francisco, 2022

Sadaat,

Marr,

Mirzazadeh

et al. 2024

AIDS Behav

View full text Add to dashboard Cite

We assessed the uptake of COVID-19 vaccination in a community-recruited sample of people who inject drugs (PWID) in San Francisco in 2022. Overall, 72.4% (95% CI 64.6–80.3) were vaccinated for COVID-19. Independent predictors of vaccination were age 65 years and older (adjusted odds ratio [AOR] 9.7, 95% CI 2.2–28.7) and ever testing positive for COVID-19 (AOR 2.0, 95% CI 1.2–3.5). Homelessness was associated with lower COVID-19 vaccination (AOR 0.5, 95% CI 0.3–0.8). Our study underscores the urgent need for targeted interventions to address unique challenges faced by PWID in accessing COVID-19 vaccination, particularly for those experiencing homelessness and who are younger.

show abstract

A systematic review and meta-analysis of the global prevalence and determinants of COVID-19 vaccine acceptance and uptake in people living with HIV

Sulaiman,

Musa,

Tsiga-Ahmed

et al. 2023

Nat Hum Behav

View full text Add to dashboard Cite

People living with HIV (PLHIV) are at higher risk of poor outcomes of SARS-CoV-2 infection. Here we report the pooled prevalence of COVID-19 vaccine acceptance/uptake and determinants among this vulnerable population of PLHIV based on a systematic review and meta-analysis of studies published by 25 August 2023. Among the 54 included studies (N = 167,485 participants), 53 (N = 166,455) provided data on vaccine acceptance rate, while 27 (N = 150,926) provided uptake data. The global prevalences of COVID-19 vaccine acceptance and uptake were 67.0% and 56.6%, respectively. Acceptance and uptake rates were 86.6% and 90.1% for the European Region, 74.9% and 71.6% for the Region of the Americas, 62.3% and 78.9% for the South-East Asian Region, 64.6% and 19.3% for the Eastern Mediterranean Region, 58.0% and 35.5% for the African Region, and 57.4% and 44.0% for the Western Pacific Region. The acceptance rate increased from 65.9% in 2020 to 71.0% in 2022, and the uptake rate increased from 55.9% in 2021 to 58.1% in 2022. Men, PLHIV aged ≥40 years and those who had recently received the influenza vaccine were more likely to accept and receive the COVID-19 vaccine. Factors associated with lower uptake included Black race, other races (Latinx/Hispanic/mixed race), low education level and being unemployed. Vaccine-related factors associated with higher acceptance included belief in vaccine effectiveness, vaccine trust, perceived high susceptibility to SARS-CoV-2 infection and fear of potential COVID-19 effect in PLHIV. Sustained efforts and targeted interventions are needed to reduce regional disparities in COVID-19 vaccine uptake among PLHIV.

show abstract

Time-to-completion of COVID-19 vaccination primary series varies by HIV viral load status among people who inject drugs in Baltimore, Maryland

Cited by 4 publications

References 33 publications

Factors Associated With COVID-19 Vaccination Among Racial/Ethnic Minority Groups With HIV in South Florida

Factors Associated With COVID-19 Vaccination Among Racial/Ethnic Minority Groups With HIV in South Florida

Uptake of COVID-19 Vaccination and Related Factors Among People who Inject Drugs, San Francisco, 2022

A systematic review and meta-analysis of the global prevalence and determinants of COVID-19 vaccine acceptance and uptake in people living with HIV

Contact Info

Product

Resources

About